Trial updateRetina
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Recruiting. Phase 1 / Phase 2. Registered enrolment: 104. Sanofi
Why it matters
Track this study through NCT07215234. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Registered enrolment
- 104
- Results posted
- No
- Sponsor
- Sanofi
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.
References (1)
Source date: 18 Sept 2026 · United States · Australia